Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8786225 | Clinical Oncology | 2018 | 6 Pages |
Abstract
Outcome data at the population level for LS-SCLC are equivalent to those reported in clinical trials. The increased use of BID schemes since 2011 did not improve survival.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
R. Damhuis, J. Widder, S. Senan,